Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC
Clinical trial NCT07242352 · RECRUITING
Trial details
- NCT number
- NCT07242352
- Sponsor
- Women's Cancer Study Group GmbH
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2033-09-30
- Enrollment
- 1520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.